Otake S - Search Results

1

Genetically manipulated bacterial toxin as a new generation mucosal adjuvant.

Yamamoto M, McGhee JR, Hagiwara Y, Otake S, Kiyono H. Yamamoto M, et al. Among authors: otake s. Scand J Immunol. 2001 Mar;53(3):211-7. doi: 10.1046/j.1365-3083.2001.00883.x. Scand J Immunol. 2001. PMID: 11251876 Free article. Review.

2

Direct effects on antigen-presenting cells and T lymphocytes explain the adjuvanticity of a nontoxic cholera toxin mutant.

Yamamoto M, Kiyono H, Yamamoto S, Batanero E, Kweon MN, Otake S, Azuma M, Takeda Y, McGhee JR. Yamamoto M, et al. Among authors: otake s. J Immunol. 1999 Jun 15;162(12):7015-21. J Immunol. 1999. PMID: 10358143

3

Alternate mucosal immune system: organized Peyer's patches are not required for IgA responses in the gastrointestinal tract.

Yamamoto M, Rennert P, McGhee JR, Kweon MN, Yamamoto S, Dohi T, Otake S, Bluethmann H, Fujihashi K, Kiyono H. Yamamoto M, et al. Among authors: otake s. J Immunol. 2000 May 15;164(10):5184-91. doi: 10.4049/jimmunol.164.10.5184. J Immunol. 2000. PMID: 10799877

4

Protective immunity to Streptococcus mutans induced by nasal vaccination with surface protein antigen and mutant cholera toxin adjuvant.

Saito M, Otake S, Ohmura M, Hirasawa M, Takada K, Mega J, Takahashi I, Kiyono H, McGhee JR, Takeda Y, Yamamoto M. Saito M, et al. Among authors: otake s. J Infect Dis. 2001 Mar 1;183(5):823-6. doi: 10.1086/318826. Epub 2001 Jan 29. J Infect Dis. 2001. PMID: 11181162

5

Specific antibodies induced by nasally administered 40-kDa outer membrane protein of Porphyromonas gingivalis inhibits coaggregation activity of P. gingivalis.

Namikoshi J, Otake S, Maeba S, Hayakawa M, Abiko Y, Yamamoto M. Namikoshi J, et al. Among authors: otake s. Vaccine. 2003 Dec 12;22(2):250-6. doi: 10.1016/s0264-410x(03)00576-0. Vaccine. 2003. PMID: 14615153

6

Transcutaneous immunization with a 40-kDa outer membrane protein of Porphyromonas gingivalis induces specific antibodies which inhibit coaggregation by P. gingivalis.

Maeba S, Otake S, Namikoshi J, Shibata Y, Hayakawa M, Abiko Y, Yamamoto M. Maeba S, et al. Among authors: otake s. Vaccine. 2005 Mar 31;23(19):2513-21. doi: 10.1016/j.vaccine.2004.10.036. Vaccine. 2005. PMID: 15752838

7

[Mitogenic activity of lipopolysaccharide from Bacteroides intermedius against C3H/HeJ mice spleen cells].

Yamamoto M, Ono K, Mochizuki S, Nishihara Y, Makimura M, Otake S. Yamamoto M, et al. Among authors: otake s. Nichidai Koko Kagaku. 1990 Sep;16(3):332-9. Nichidai Koko Kagaku. 1990. PMID: 2134944 Japanese.

8

Expression profile of chemokines and chemokine receptors in epithelial cell layers of oral lichen planus.

Ichimura M, Hiratsuka K, Ogura N, Utsunomiya T, Sakamaki H, Kondoh T, Abiko Y, Otake S, Yamamoto M. Ichimura M, et al. Among authors: otake s. J Oral Pathol Med. 2006 Mar;35(3):167-74. doi: 10.1111/j.1600-0714.2006.00402.x. J Oral Pathol Med. 2006. PMID: 16454813

9

Virulence of Streptococcus mutans: characterization of a serotype g antigen-defective mutants and its revertants.

Otake S, Hirasawa M, Brown TA, Kawabata Y, Kiyono H, Michalek SM, McGhee JR, Shiota T. Otake S, et al. Infect Immun. 1981 Jan;31(1):151-9. doi: 10.1128/iai.31.1.151-159.1981. Infect Immun. 1981. PMID: 6452413 Free PMC article.

10

Use of mutants in the elucidation of virulence of Streptococcus mutans.

Otake S, McGhee JR, Hirasawa M, Williams K, Arnold RR, Babb JL, Kiyono H, Cox C, Michalek SM, Shiota T, Ikeda T, Ochiai K. Otake S, et al. Adv Exp Med Biol. 1978;107:673-83. doi: 10.1007/978-1-4684-3369-2_76. Adv Exp Med Biol. 1978. PMID: 742506 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

320 results

Search Page

Filters